From Plan to Impact report launch
The report launch of From Plan to Impact IV: Progress towards targets of the WHO Global action plan on dementia will take place virtually on 26 May.
News & events
News, conferences, events, blogs and updates from across the field of dementia and the work of Alzheimer's Disease International.
Featured news and events
ADI Council Meeting of 2021
The ADI Council met on 30 March 2021 to discuss ADI's activities over 2020, new membership applications and more.
ADI and ITN Productions release new documentary ‘Hope in the Age of Dementia’
Alzheimer’s Disease International (ADI) and ITN Productions have co-produced a new documentary ‘Hope in the Age of Dementia'.
Diagnosis, treatment, care and support during COVID-19
The following piece is from our third 'From Plan to Impact' report and written by ADI's Communications and Policy Manager, Annie Bliss, the main author of the report. In this piece, she writes about the impact of the COVID-19 pandemic on diagnostic, treatment, care and support services for people living with dementia.
Governments must heed the lessons of COVID-19 and the disproportionate impact for people with dementia
A new report by ADI calls on world governments to ensure that dementia remains a priority during and after the COVID-19 pandemic.
Alzheimers New Zealand responds to COVID-19, then and now
Catherine Hall, Chief Executive of Alzheimers New Zealand, writes about how Alzheimers New Zealand has responded and adapted to COVID-19, both in the first weeks of lockdown and today.
ADI and DAI join others in statement to WHO about non-communicable diseases and the global COVID-19 response
Alzheimer’s Disease International (ADI) and partner Dementia Alliance International (DAI) join other civil society organisations in a statement to the World Health Organization (WHO).
ADI submits statement on dementia and COVID-19 ahead of World Health Assembly
In advance of the 73rd World Health Assembly, ADI is sharing a statement submitted to the World Health Organization (WHO) and Member States.
New blood test research for diagnosis of Alzheimer’s disease shows promising results
A new study in the Lancet Neurology has shown that blood phosphorylated tau 181 may be a promising biomarker for Alzheimer’s disease.
ADI welcomes new Associations and Board members
ADI welcomes three new Alzheimer associations, as well as new members to the ADI board.